Recommended by professional guidelines for the treatment of Irritable Bowel Syndrome (IBS)
Know more about i3.1:
i3.1 is endorsed by several top-class gastrointestinal societies:
Probiotics and prebiotics guideline, as a clinically-tested treatment for IBS
German S3-guideline for IBS, as a recommended microbiota-modulator treatment
Visceral hypersensitivity is defined as the abnormal sensation of intestinal pain, commonly found in IBS patients
AB-KOLICARE presents a well-described and unique mechanism of action:
Proprietary probiotic strains naturally found in the gut of healthy individuals. Only essential ingredients
Can be taken together with anti-spasmodics to increase therapeutic benefits, specially for abdominal pain
Improves general symptoms of lactose intolerance, including pain, flatulence and diarrea
Three clinical trials with IBS and lactose intolerant patients. Safety approved by EFSA and FDA